Leading Pharma
United States 107 employees Updated 9 July 2026
Leading Pharma is a finished-dose manufacturer based in United States. It appears in 32 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with US FDA and DMP (NO). Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 21 October 2024 as VAI.
1
registered plants
1 with an FDA FEI number
32
filings
across 2 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 21 October 2024 VAI US FDA
- 11 August 2020 NAI US FDA
- 31 January 2019 VAI US FDA
- 31 August 2018 NAI US FDA
- 14 April 2017 VAI US FDA
- 10 March 2016 VAI US FDA
- 6 March 2015 VAI US FDA
- 12 June 2013 NAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Fairfield, United States | 3001611969 |
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| US FDA | 30 | 1 |
| DMP (NO) | 2 | None |
Comparing suppliers?
Choose your molecules and target markets. Leading Pharma comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was VAI, on 21 October 2024.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates